Systemic Sclerosis-associated Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis-associated Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-06EMA Authorised: Ofev (nintedanib) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorised a label expansion for Ofev (nintedanib) to cover additional interstitial lung diseases, including s…
-
FDA approval · 2016-02-04FDA Approved: OFEV — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for OFEV (nintedanib) filed by Boehringer Ingelheim Pharmaceuticals, Inc., expanding its approved us…